Drug Pharmacy Compounding
Instructor:
Rachelle D Souza
Product ID: 704907
Training Level: Basic to Intermediate
- Duration: 60 Min
Why Should You Attend:
Do you know of sections 503A and 503B of the Federal Food, Drug and Cosmetic Act (FDCA) as it relates to drug compounding?
Section 503A provides conditions under which certain compounded human drug products are exempted from requirements such as compliance with current good manufacturing practices (CGMPs), labeling with adequate directions for use and FDA market approval. New section 503B of the FDCA enables a compounder to register with FDA to become an “outsourcing facility.” Outsourcing facilities are exempt from the above label compliance and FDA market approval requirements but are still subject to CGMP compliance, risk based FDA inspections and certain reporting requirements such as adverse event reporting.
This training seeks to inform hospital or stand-alone pharmacies, pharmacy state boards, pharmacists, health care professionals, hospitals on the various FDA documents including the latest developments concerning this topic.
Learning Objectives:
To practice pharmacy drug compounding under a state of quality compliance and without violation of the law.
Areas Covered in the Webinar:
- Sections 503A and 503B, FDCA & various FDA documentation concerning this topic
- Outsourcing facility registration and reporting
Who will Benefit:
- Hospitals or stand-alone pharmacies
- Pharmacy state boards
- Pharmacists
- Health care professionals
- Compliance officers
- Documentation specialists
Rachelle D Souza
CEO and President, Regulatory Heights Inc
Rachelle D’Souza, CEO of Regulatory Heights Inc., has successfully licensed various medical and consumer products and facilities with international regulatory authorities / agencies for multinational and start-up companies.
Her expertise also includes clinical trial master file documentation, and the design and maintenance of globally compliant quality, safety / pharmacovigilance and medical information systems.
At Regulatory Heights Inc., Rachelle continuously monitors the current regulatory environment and utilizes regulatory intelligence as a strategic business driver for her clientele. Her numerous articles on the latest international regulatory developments have been published in print and on-line by regulatory professional associations and industry magazines around the world.
Her versatility has enabled Regulatory Heights Inc. to support companies, in particular, start-ups with the licensing of their drugs and medical devices in international markets.
Refund Policy
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
